Live Help
Want to know more
Enter the details and we'll call you soon

Name :

Company Name :

City :

Mobile No. :

Email id :

  

Thank you for your details



Our Executive will reach you shortly.

Your Session Will Expire in   seconds.
If you do not wish to log-out, choose 'Let me continue'
Reset SessionCancel Session
 

NCLAT sets aside Sterling Biotech liquidation, allows its promoters to take back control of the company

September 4, 2019[2019] 109 taxmann.com 30 (NCL-AT)
366 Views

IBC : Where application filed for withdrawal of CIRP under section 12A by promoter was approved by Committee of Creditors by more than 90 per cent voting share, same could not be rejected on ground that 'Promoter' not eligible to file 'resolution plan' under section 29A cannot file application under section 12A

read more

taxmann.com
Payment
Best view in 1140 x 768